Abstract
Mitochondrial dysfunction and mutations in mitochondrial DNA have been frequently reported in cancer cells. Mitochondrial gene-expression signatures of transformed cells have been identified; however, the phenotypic effects of these genetic alterations remain to be established. Identification of mitochondrial proteins that are aberrantly expressed in cancer cells has been made possible by the recent development of mitochondrial functional proteomics and could identify new markers for early detection and risk assessment, as well as targets for therapeutic intervention.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fliss, M. S. et al. Facile detection of mitochondrial mutations in tumours and body fluids. Science 287, 2017–2019 (2000).
Costantini, P., Jacotot, E., Decaudin, D. & Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl Cancer Inst. 92, 1042–1053 (2000).
Kroegmer, G. Mitochondrial control of aopotosis. Biochem. Soc. Symp. 66, 1–15 (1999).
Thress, K., Kornbluth, S. & Smith, J. J. Mitochondria at the crossroad of apoptotic cell death. Mitochondria at the crossroad of apoptotic cell death. J. Bioenerg. Biomembr. 31, 321–326 (1999).
Fernandez, M. G. et al. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ. 13, 449–455 (2002).
Alonso, A. et al. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 18, 682–685 (1997).
Anderson, L. & Seilamer, J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533–537 (1997).
Jeronimo, C. et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20, 5195–5198 (2001).
Jones, J. B. et al. Detection of mitochondrial DNA mutations in pancreatic cancer offers a 'mass'-ive advantage over detection of nuclear DNA mutations. Cancer Res. 61, 1299–1304 (2001).
Copeland, W., Waschman, J., Johnson, J. & Penta, J. Mitochondrial DNA alterations in cancer. Cancer Invest. 20, 557–569 (2002).
Ha, P. K. et al. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res. 8, 2260–2265 (2002).
Sanchez–Cespedes et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 61, 7015–7019 (2001).
Parrella, P. et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61, 7623–7626 (2001).
Nomoto, S., Yamashita, K., Koshikawa, K., Nakao, A. & Sidransky, D. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin. Cancer Res. 8, 481–487 (2002).
Eng, C. Kiuru, M., Fernandez, M. J. & Aaltonen, L. A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nature Rev. Cancer 3, 193–202 (2003).
Lopez, M. F. & Melov, S. Applied proteomics: mitochondrial proteins and effect on function. Circ. Res. 90, 380–389 (2002)
Tan, D. J. et al. Novel heteroplasmic frameshift and missense somatic mitochondrial DNA mutations in oral cancer of betel quid chewers. Genes Chromosom. Cancer 37, 186–194 (2003).
Murray, J., Gilkerson, R. & Capaldi, R. A. Quantitative proteomics: the copy number of pyruvate dehydrogenase is more than 102 fold lower than that of complex III in human mitochondria. FEBS Lett. 529, 173–178 (2002).
Petricoin, E. F. & Liotta, L. A. Mass spectrometry based diagnostics: the upcoming revolution in disease detection. Clin. Chem. 49, 533–534 (2003).
Vissers, J. P., Blackburn, R. K., & Moseley, M. A. A novel interface for variable nanoscale LC/MS for improved proteome coverage. J. Am. Soc. Mass Spectrom. 13, 760–771 (2002).
Brookes, P. S. et al. High-throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signaling complexes. Proteomics 2, 969–977 (2002).
Tryoen-Toth P. et al. Proteomic consequences of a human mitochondrial tRNA mutation beyond the frame of mitochondrial translation. J. Biol. Chem. 278, 24314–24323 (2003).
Anderson, N. L. & Anderson, N. G. Proteome and proteomics: new technologies, new concepts and new words. Electrophoresis 19, 1853–1861 (1998).
Gygi, S. P., Rochon, Y., Franza, B. B. & Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 19, 1720–1730 (1999).
Zhou, G. et al. 2D Differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 1, 117–123 (2002).
Wall, D. B. et al. Three-dimensional protein map according to pI, hydophobicity and molecular mass. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 774, 53–58 (2002).
Merchant, M. & Weinberger, S. R. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21, 1164–1177 (2000).
Fung, E. T. & Enderwick, C. ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques 34, 40–41 (2002).
Lin, T. K. et al. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J. Biol. Chem. 277, 17048–17056 (2002).
Yu, W. et al. RRR-α-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res. 63, 2483–2491 (2003).
Lopez, M. F. et al. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis 21, 3427–3440 (2000).
Rabilloud, T. et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: toward a human mitochondrial proteome. Electrophoresis 19, 1006–1014 (1998).
Sidransky, D. Emerging molecular markers of cancer. Nature Rev. Cancer 2, 210–219 (2002).
Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482–1488 (1999).
Tong, B. C. et al. Mitochondrial DNA alterations in thyroid cancer. J. Surg. Oncol. 82, 170–173 (2003).
Mambo, E. et al. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc. Natl Acad. Sci. USA 100, 1838–1843 (2003).
Hirano, M. et al. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin. Cell Dev. Biol. 12, 417–427 (2001).
Kaukonen, J. et al. A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia. Am. J. Hum. Genet. 65, 256–261 (1999).
Mitsumoto, A., Takeuchi, A., Okawa, K. & Nakagawa, Y. A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. Free Radic. Biol. Med. 32, 22–37 (2002).
Scheffler, I. E. Mitochondria make a come back. Adv. Drug. Deliv. Rev. 49, 3–26 (2001).
Rabilloud, T. et al. The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1, 1105–1110 (2001).
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
DATABASES
Cancer.gov
LocusLink
FURTHER INFORMATION
Early Detection Research Network
Rights and permissions
About this article
Cite this article
Verma, M., Kagan, J., Sidransky, D. et al. Proteomic analysis of cancer-cell mitochondria. Nat Rev Cancer 3, 789–795 (2003). https://doi.org/10.1038/nrc1192
Issue Date:
DOI: https://doi.org/10.1038/nrc1192
This article is cited by
-
Multifunctional Enveloped Mesoporous Silica Nanoparticles for Subcellular Co-delivery of Drug and Therapeutic Peptide
Scientific Reports (2014)
-
Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
EPMA Journal (2013)
-
Targeting proteomics to investigate metastasis-associated mitochondrial proteins
Journal of Bioenergetics and Biomembranes (2012)
-
Proteomic analysis in cancer research: potential application in clinical use
Clinical & Translational Oncology (2006)